- Home
- RCKT vs ACV Comparison
RCKT vs ACV Comparison
Compare RCKT & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCKT | ACV |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.3M | 246.2M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | RCKT | ACV |
|---|---|---|
| Price | $2.39 | $22.76 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $8.58 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 32.9K |
| Earning Date | 11-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.20% |
| EPS Growth | ★ 26.37 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $915.60 | N/A |
| P/E Ratio | $3.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.17 | $23.04 |
| 52 Week High | $5.45 | $29.04 |
Technical Indicators
Market Signals| Indicator | RCKT | ACV |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 33.31 |
| Support Level | $2.17 | N/A |
| Resistance Level | $2.73 | $28.24 |
| Average True Range (ATR) | 0.18 | 0.57 |
| MACD | 0.05 | -0.06 |
| Stochastic Oscillator | 64.00 | 10.09 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.